Key result
Tamoxifen was identified as the most acceptable alternative internal standard for amiodarone assay, yielding linear standard curves and low within-run and between-run CVs.
Systematic Review
Tamoxifen serves as an effective internal standard for the routine liquid chromatographic assay of amiodarone and its metabolite, replacing the no longer available L8040.
Answers are grounded in this paper and cite their sources.
Supports uninterrupted amiodarone therapeutic drug monitoring; extends assay methods by validating tamoxifen as an accessible internal standard.
Despite potential adverse effects, clinical use of amiodarone is increasing because of its efficacy in treating arrhythmias. Thus there is a continued need for a rapid, practical amiodarone assay to better study the relationship between serum concentrations and clinical effects and to guide safer dosing. Because the most widely used internal standard, L8040, is no longer available, a systematic comparison of potential alternatives was undertaken based on physicochemical and chromatographic characteristics. All amiodarone assays indexed on Medline were reviewed to produce a list of alternatives and five other potential substances considered based on previous experiences. An isocratic high-performance liquid chromatographic method was modified to allow simultaneous resolution of multiple compounds. The internal standard was expected to perform well in the solid-phase extraction of small sample volumes. No commercially available substances were able to duplicate all the advantages of L8040. Tamoxifen, the most acceptable alternative, was used to develop an assay to measure amiodarone and desethylamiodarone at concentrations as low as 0.25 mg/L in 100 microliters of serum (5 ng detected in a 20 microliters injection). Standard curves were linear over the range of concentrations found in our patients (0.25 to 8 mg/L), within-run coefficients of variation (CVs) averaged 5.3% for amiodarone and 2.9% for desethylamiodarone, and between-run CVs were 4.5% for amiodarone and 1.6% for desethylamiodarone.
No takes yet. Share an insight, caveat, or question.
P. Timothy Pollak (1996) conducted a systematic review in Arrhythmias (Amiodarone assay development). Tamoxifen as an internal standard vs. L8040 and other alternatives was evaluated on Assay performance (linearity and coefficients of variation). Tamoxifen was identified as the most acceptable alternative internal standard for amiodarone assay, yielding linear standard curves and low within-run and between-run CVs.
Synapse has enriched 10 related papers. Consider them for comparative context: